A Formidable Partnership in Health Research and Medical Education

~ NIH and IMU deepens cooperation with signing of MoU ~

Kuala Lumpur, 26 July 2018 – The National Institutes of Health (NIH) has signed a Memorandum of Understanding (MoU) with the International Medical University (IMU) that will see both parties collaborating and exchanging industry knowledge to further elevate the areas of medical education and health research in the country. The signing ceremony was held today at the University’s Bukit Jalil campus. The MoU was signed between Prof Abdul Aziz Baba, Vice-Chancellor of IMU and YBhg Datuk Dr Shahnaz Binti Murad, Deputy Director General of Health (Research and Technical Support Programme), Ministry of Health Malaysia. “We are delighted to sign this memorandum that will enable IMU and NIH to work closely together and deepen our cooperation on health research and medical education with the single objective of bringing both areas to greater heights in the country,” says Prof Abdul Aziz. “Excellence in research and medical education goes hand in hand. The collaboration between IMU and NIH will result in great opportunities for both parties to learn from one another as well as exchange ideas on how to develop and expand the medical education and health research in the region.”

“Research in healthcare is becoming increasingly complex. It is increasingly important that decisions are made based on solid evidence especially in times with limited resources. Therefore, it is imperative that we work together to make the most impact on health and healthcare for the benefits of the rakyat of Malaysia. I look forward to the fruitful cooperation and collaboration between IMU and NIH to make this happen,” says Datuk Dr Shahnaz Binti Murad, Deputy Director General of Health (Research and Technical Support Programme), Ministry of Health Malaysia.

NIH is a network of six research institutions under the Ministry of Health, namely Institute for Medical Research (IMR), Institute for Public Health (IPH), Institute for Health System Research (IHSR), Institute for Health Management (IHM), Institute for Health Behavioural Research (IHBR) and Clinical Research Centre Network (CRC). All six research institutions have significantly contributed to the development of healthcare services and research in the country as well as have won awards globally.

Meanwhile, IMU is known for its quality medical education and focus on enhancing research activities in its curriculum. The premier private medical university has an extensive international partnership with more than 20 established world-renown universities across the globe in providing world-class quality education. Via the collaboration, both parties will look forward to working closely together through joint appointments (visiting professors and visiting scientists), access to research and teaching resources such as laboratory facilities, specialised equipment and literatures, collaborative research and human resource development. “Malaysia’s healthcare industry will certainly thrive with collaborations such as ours. In healthcare, history has shown that working hand in hand with partners in the same industry will yield amazing results that will benefit the community as a whole. In line with our focus to maintain the highest standards in our core areas of Education, Healthcare and Research, IMU is open to similar collaborations with NIH to pursue an objective that will bring positive results not just to the parties involved but the healthcare fraternity as a whole,” says Prof Abdul Aziz.

International Medical University
Founded in 1992, the IMU is Malaysia’s first and most established full-fledged private medical and health sciences university. Today, the IMU offers over 20 health professional programmes at pre-university, undergraduate and postgraduate levels in Medicine, Dentistry, Pharmacy, Health Sciences, and Postgraduate Studies. IMU has established a solid global network that provides students with greater learning and training opportunities through its credit-transfer agreements with over 30 world’s prestigious universities. In the IMU, students are aspired to be future healthcare professionals who are committed to lifelong learning and imbued with a sense of good citizenship, leadership and ethical behaviour. International Medical University is a medical education arm of IHH Healthcare Berhad (5225) (IHH), a public listed company in Bursa Malaysia and the Singapore Stock Exchange. IHH is a leading international provider of premium integrated healthcare services operating in the home markets of Malaysia, Singapore, Turkey and India. The Group also has a growing presence in China and an expanding network across Asia and Central and Eastern Europe, the Middle East and North Africa (“CEEMENA”). Known as one of the largest listed healthcare groups in the world, IHH presently operates over 10,000 licensed beds in 50 hospitals across 10 countries. For more information please visit IMU website at www.imu.edu.my or its blog at https://imunews.imu.edu.my.

International Medical University

Founded in 1992, the IMU is Malaysia’s first and most established full-fledged private medical and health sciences university. Today, the IMU offers over 20 health professional programmes at pre-university, undergraduate and postgraduate levels in Medicine, Dentistry, Pharmacy, Health Sciences, and Postgraduate Studies. IMU has established a solid global network that provides students with greater learning and training opportunities through its credit-transfer agreements with over 30 world’s prestigious universities. In the IMU, students are aspired to be future healthcare professionals who are committed to lifelong learning and imbued with a sense of good citizenship, leadership and ethical behaviour. International Medical University is a medical education arm of IHH Healthcare Berhad (5225) (IHH), a public listed company in Bursa Malaysia and the Singapore Stock Exchange. IHH is a leading international provider of premium integrated healthcare services operating in the home markets of Malaysia, Singapore, Turkey and India. The Group also has a growing presence in China and an expanding network across Asia and Central and Eastern Europe, the Middle East and North Africa (“CEEMENA”). Known as one of the largest listed healthcare groups in the world, IHH presently operates over 10,000 licensed beds in 50 hospitals across 10 countries. For more information please visit IMU website at www.imu.edu.my or its blog at https://imunews.imu.edu.my.

National Institutes of Health
NIH is a network of six research institutions under the Ministry of Health namely Institute for Medical Research (IMR), Institute for Public Health (IPH), Institute for Health System Research (IHSR), Institute for Health Management (IHM), Institute for Health Behavioural Research (IHBR) and Clinical Research Centre Network (CRC). IMR is a premier biomedical research institute with a long-standing tradition in research spanning over more than 118 years especially in tropical medicine. It has significantly contributed to the development of healthcare services in the country especially in the area of laboratory diagnostics, treatment and control of many of the tropical diseases, recognised internationally and has recently won the prestigious Dr Lee Joon-Wook Memorial Prize for Public Health by the WHO for their innovation in the development, production and provision of maggot therapy for difficult wound ulcer. It is also a WHO Collaborating Centre for Vectors of Malaria, Filariasis and Dengue.

National Institutes of Health

NIH is a network of six research institutions under the Ministry of Health namely Institute for Medical Research (IMR), Institute for Public Health (IPH), Institute for Health System Research (IHSR), Institute for Health Management (IHM), Institute for Health Behavioural Research (IHBR) and Clinical Research Centre Network (CRC). IMR is a premier biomedical research institute with a long-standing tradition in research spanning over more than 118 years especially in tropical medicine. It has significantly contributed to the development of healthcare services in the country especially in the area of laboratory diagnostics, treatment and control of many of the tropical diseases, recognised internationally and has recently won the prestigious Dr Lee Joon-Wook Memorial Prize for Public Health by the WHO for their innovation in the development, production and provision of maggot therapy for difficult wound ulcer. It is also a WHO Collaborating Centre for Vectors of Malaria, Filariasis and Dengue.